Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NBIX - Neurocrine Biosciences, Inc.
-487 M
LAST VALUE
-44.13%
2 YEAR CAGR
-79.85%
5 YEAR CAGR
-16.25%
10 YEAR CAGR